FDA OKs implant for enlarged prostate symptoms

Published



WASHINGTON (AP) — Federal health regulators have approved the first permanent implant to treat men’s urinary problems caused by an enlarged prostate.

The Food and Drug Administration says it approved the Urolift system to relieve low or blocked urine flow in men age 50 or older. The implant works by holding back prostate tissue that presses against the urethra, causing difficulty urinating.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.